CELZ stock forecast
Our latest prediction for Creative Medical Technology Holdings Inc's stock price was made on the July 3, 2023 when the stock price was at 4.52$.
In the short term (2weeks), CELZ's stock price should underperform the market by -4.11%. During that period the price should oscillate between -12.12% and +3.05%.
In the medium term (3months), CELZ's stock price should underperform the market by -18.15%. During that period the price should oscillate between -36.06% and +8.95%.Get email alerts
Create a solid portfolio with CELZ
About Creative Medical Technology Holdings Inc
creative medical technology holdings, inc., through its subsidiaries, engages in the stem cell research and developing applications to treat male sexual dysfunction and related issues. the company markets its erectile dysfunction (ed) treatment under the caverstem name to physicians for use with their patients suffering from ed. creative medical technology holdings, inc. was incorporated in 1998 and is based in phoenix, arizona. creative medical technology holdings, inc. is a subsidiary of creative medical health, inc.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.93$ per share.
The book value per share is 1.65$
Three months stock forecastJuly 3, 2023
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|